Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 35 studies | 39% ± 16% | |
pericyte | 24 studies | 38% ± 21% | |
endothelial cell of lymphatic vessel | 16 studies | 34% ± 16% | |
endothelial cell of vascular tree | 12 studies | 38% ± 14% | |
smooth muscle cell | 11 studies | 33% ± 16% | |
capillary endothelial cell | 8 studies | 35% ± 12% | |
vein endothelial cell | 7 studies | 30% ± 15% | |
endothelial cell of artery | 5 studies | 37% ± 8% | |
oligodendrocyte | 5 studies | 28% ± 7% | |
retinal pigment epithelial cell | 4 studies | 35% ± 24% | |
Mueller cell | 4 studies | 43% ± 7% | |
glomerular endothelial cell | 3 studies | 47% ± 8% | |
lymphocyte | 3 studies | 24% ± 9% | |
astrocyte | 3 studies | 26% ± 10% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 25% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 99% | 11320.52 | 646 / 653 | 94% | 46.68 | 567 / 605 |
breast | 100% | 21060.01 | 458 / 459 | 84% | 16.76 | 944 / 1118 |
brain | 82% | 4556.06 | 2157 / 2642 | 98% | 44.83 | 692 / 705 |
prostate | 72% | 2933.42 | 176 / 245 | 85% | 17.27 | 425 / 502 |
bladder | 81% | 3714.10 | 17 / 21 | 63% | 13.64 | 320 / 504 |
lung | 76% | 3838.01 | 439 / 578 | 58% | 7.99 | 674 / 1155 |
stomach | 57% | 1909.30 | 205 / 359 | 77% | 18.75 | 220 / 286 |
intestine | 59% | 2313.17 | 567 / 966 | 70% | 18.30 | 371 / 527 |
esophagus | 62% | 2446.47 | 890 / 1445 | 67% | 10.42 | 122 / 183 |
uterus | 82% | 4399.85 | 140 / 170 | 44% | 6.37 | 200 / 459 |
skin | 54% | 2363.87 | 974 / 1809 | 67% | 16.55 | 316 / 472 |
kidney | 46% | 2019.60 | 41 / 89 | 73% | 83.05 | 654 / 901 |
adrenal gland | 26% | 1052.74 | 68 / 258 | 84% | 36.59 | 193 / 230 |
pancreas | 16% | 380.00 | 53 / 328 | 92% | 20.13 | 164 / 178 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.41 | 1 / 1 |
adipose | 100% | 27302.78 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 92% | 4479.12 | 735 / 803 | 0% | 0 | 0 / 0 |
heart | 88% | 5382.49 | 759 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 81% | 7234.11 | 1077 / 1335 | 0% | 0 | 0 / 0 |
liver | 5% | 108.63 | 11 / 226 | 64% | 9.28 | 261 / 406 |
ovary | 23% | 1119.94 | 41 / 180 | 34% | 3.23 | 148 / 430 |
tonsil | 0% | 0 | 0 / 0 | 44% | 5.80 | 20 / 45 |
spleen | 30% | 913.66 | 72 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 14% | 1.21 | 4 / 29 |
eye | 0% | 0 | 0 / 0 | 5% | 0.45 | 4 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001525 | Biological process | angiogenesis |
GO_0045601 | Biological process | regulation of endothelial cell differentiation |
GO_0030154 | Biological process | cell differentiation |
GO_0042157 | Biological process | lipoprotein metabolic process |
GO_0006869 | Biological process | lipid transport |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0008289 | Molecular function | lipid binding |
Gene name | APOLD1 |
Protein name | Apolipoprotein L domain containing 1 Apolipoprotein L domain containing 1 (HCG1658737, isoform CRA_b) (cDNA, FLJ95166) Apolipoprotein L domain-containing protein 1 (Vascular early response gene protein) |
Synonyms | VERGE hCG_1658737 |
Description | FUNCTION: May be involved in angiogenesis. May play a role in activity-dependent changes of brain vasculature. May affect blood-brain permeability. . |
Accessions | ENST00000356591.5 [Q96LR9-2] ENST00000540583.5 Q96LR9 ENST00000326765.10 [Q96LR9-1] F5GX34 ENST00000534843.1 A0AVN6 |